期刊文献+

抗早产药的临床应用与分析 被引量:3

Analysis on the Clinical Application of Anti-preterm Labor Medicines
原文传递
导出
摘要 目的:评价我院抗早产药的临床应用,促进合理用药。方法:对我院2005年95例使用抗早产药的早产病例进行回顾性调查分析。结果:抗早产药治疗早产有4种方案,其中硫酸沙丁胺醇片、硫酸沙丁胺醇片联合硫酸镁注射液是我院治疗早产常用的治疗方案;硫酸镁注射液是患妊娠高血压疾病早产孕妇的治疗方案;单独使用硫酸沙丁胺醇片仅用于32孕周以上的早产孕妇。结论:抗早产药在临床应用中存在不合理现象,需加强抗早产药不良反应的监测,保证母婴健康。 OBJECTIVE: To evaluate the clinical application of anti- preterm labor medicines in our hospital and to promote rational drug use.METHODS: The anti - preterm labor medicines used in 95 cases with preterm labor in our hospital in 2005 are analyzed retrospectively. RESULTS:There were four anti - preterm labor schemes.Of which, the scheme of salbutamol sulfate tablets and salbutamol sulfate tablets in combination with magnesium sulfate injections was commonly used for preterm labor in our hospital; magnesium sulfate injection was the therapy for pregnant women with preterm labor complicating gestational hypertension; oral salbutamol sulfate tablets alone only used for pregnant women with more than 32 gestational weeks.CONCLUSION:The clinical use of anti- preterm labor medicines is far from perfect in our hospital.Monitoring on the ADRs of anti - preterm labor medicines should be strengthened to ensure the health of both mother and baby.
出处 《中国药房》 CAS CSCD 北大核心 2007年第29期2258-2259,共2页 China Pharmacy
关键词 早产 抗早产药 用药分析 Preterm labor Anti - perterm labor medicines Analysis of drug use
  • 相关文献

参考文献3

  • 1周淑群.硫酸舒喘灵在妇产科中的临床应用[J].中国药房,2005,16(19):1506-1508. 被引量:5
  • 2童小彤.防止早产的上佳选择——安宝 [J].中国药房,1999,10(4):164-164.
  • 3Gyetvai K, Hannah ME, Hodett ED, et al .Tocolytics for prettier labour: a systematic review [J]. Obstet Gynecol, 1994,94(5pt2) : 869.

二级参考文献15

共引文献8

同被引文献22

  • 1曹忠志,朱小三.硫酸镁在临床应用中的问题[J].中国医药导报,2006,3(8). 被引量:6
  • 2Yokyama K, Takahashi N, Yada Y. Prolonged maternal magnesium administration and bone metabolism in neonates[J]. Early Hum Dev, 2010,86(3): 187-191.
  • 3Wedig K E, Kogan J, Schorry E K, et al. Skeletal demineralization and fractures caused by fetal magnesium toxicity[J]. J Perinatol, 2006,26(3):371-374.
  • 4Malaeb S N, Rassi A, Haddad M C. Bone mineralization in new- borns whose mothers received magnesium sulphate for tocolysis of premature labor[J].PediatrRadiol, 2004,34(5):384-386.
  • 5Kaplan W, Haymond M W, Mckay S, et al. Osteopenic effects of magnesium sulfate in multiple pregnancies[J].Pediatric Endocrinol- ogy and Metabolism, 2006,19(10): 1225-1230.
  • 6Schanler R J, Smith G, Burns P A. Effects of long-term maternal intravenous magnesium sulfate therapy on neonatal calcium metabolism and bone mineral content[J]. GynecolObstetlnvest,1997, 43(4):236-241.
  • 7Nassar A H, Sakhei K, Maarouf H, et al. Adverse maternal and neonatal outcome of prolonged course of magnesium sulfate tocolysis[J].ActaObstetGynecol Scan, 2006,85(9):1099-1103.
  • 8Matsuda Y, Maeda Y, Ito M, et al. Effect of magnesium sulfate treatment on neonatal bone abnormalities [J]. GynecolObstetlnvest, 1997,44(2):82-88.
  • 9A. Konda,A. Nodai,M. Soma,Y. Koga,H. Yoshida,T. Toda,T. Hayakawa,N. Inotsume. Ritodrine pharmacokinetics in twin pregnancy patients[J] 2008,European Journal of Clinical Pharmacology(4):399~404
  • 10刘芬,丁依玲.早产的药物治疗[J].中国医刊,2007,42(12):63-66. 被引量:6

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部